Health Highlights: Sept. 20, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: California Sues Drug Maker AbbVie for Allegedly Paying Doctors to Prescribe Humira A lawsuit filed Tuesday in California claims that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 20, 2018 Category: General Medicine Source Type: news

Suit targets AbbieVie for alleged kickback scheme
Regulators in California are suing AbbieVie for an alleged kickback scheme that boosted prescriptions for its blockbuster medication, Humira. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 19, 2018 Category: Pharmaceuticals Source Type: news

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira
WEDNESDAY, Sept. 19, 2018 -- A lawsuit filed Tuesday in California claims that pharmaceutical company AbbVie used cash, gifts, and services to induce doctors to overprescribe the widely used drug Humira (adalimumab), ignoring the medicine ' s... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 19, 2018 Category: Pharmaceuticals Source Type: news

AbbVie shares fall after being sued by California over Humira allegations
The California Insurance Commissioner is suing AbbVie Inc., claiming the Illinois drug giant "gave illegal kickbacks to health care providers to prescribe" its Humira rheumatoid arthritis drug. In his lawsuit, Insurance Commissioner Dave Jones alleged AbbVie (NYSE: ABBV) "has engaged in a far-reaching scheme including both 'classic' kickbacks — cash, meals, drinks, gifts, trips, and patient referrals — and more sophisticated ones — free and valuable professional goods and services to physicians… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 19, 2018 Category: Biotechnology Authors: Ben Miller Source Type: news

AbbVie shares fall after being sued over Humira allegations
The California Insurance Commissioner is suing AbbVie Inc., claiming the Illinois drug giant "gave illegal kickbacks to health care providers to prescribe" its Humira rheumatoid arthritis drug. In his lawsuit, Insurance Commissioner Dave Jones alleged AbbVie (NYSE: ABBV) "has engaged in a far-reaching scheme including both 'classic' kickbacks — cash, meals, drinks, gifts, trips, and patient referrals — and more sophisticated ones — free and valuable professional goods and services to physicians… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 19, 2018 Category: Biotechnology Authors: Ben Miller Source Type: news

Health Highlights: Sept. 19, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: California Sues Drug Maker AbbVie for Allegedly Paying Doctors to Prescribe Humira A lawsuit filed Tuesday in California claims that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 19, 2018 Category: General Medicine Source Type: news

California Sues AbbVie Over Alleged Kickback Scheme for Humira California Sues AbbVie Over Alleged Kickback Scheme for Humira
The complaint was prompted by a ' whistleblower ' who said AbbVie allegedly hired nurses ' nationwide ' to represent themselves as patient advocates when they were really company ambassadors ' hired to...keep patients on a dangerous drug at any cost, ' according to the state ' s insurance commissioner.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news

California sues maker of Humira for alleged kickbacks to doctors
California filed a lawsuit Tuesday accusing pharmaceutical giant AbbVie of illegally plying doctors with cash, gifts and services to prescribe Humira despite its potentially deadly complications. (Source: CBC | Health)
Source: CBC | Health - September 18, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

California insurance regulator sues AbbVie alleging Humira kickbacks
Insurance Commissioner Dave Jones on Tuesday filed a complaint on behalf of the State of California against AbbVie Inc, alleging the drugmaker gave illegal kickbacks to healthcare providers to prescribe its blockbuster drug, Humira. (Source: Reuters: Health)
Source: Reuters: Health - September 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

California: Drugmaker paid doctors to overprescribe Humira
California has filed a lawsuit accusing pharmaceutical giant AbbVie of illegally plying doctors with cash, gifts and services to prescribe one of the world's biggest selling drugs (Source: ABC News: Health)
Source: ABC News: Health - September 18, 2018 Category: Consumer Health News Tags: Health Source Type: news

California sues AbbVie over alleged Humira kickbacks
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 18, 2018 Category: Pharmaceuticals Source Type: news

Cyltezo-Phase III -in Psoriasis
Biosimilar Cyltezo ® demonstrates clinical equivalence to Humira® in patients with moderate-to-severe plaque psoriasisData show that Cyltezo © (adalimumab- adbm) and Humira®* have similar efficacy, safety and immunogenicity in people with moderate-to-severe chronic plaque psoriasis1At week 16, the study met the primary endpoint, demonstrating clinical equivalence to Humira ®1Data will be presented at the European Association of Dermatology and Venereology Annual Meeting (EADV 2018) (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - September 12, 2018 Category: Research Source Type: news

Europe ready to cash in on cheap copies of AbbVie biotech drug
U.S. drugmaker AbbVie ABBV.N faces a crunch moment in Europe in mid-October when less-expensive copies of its $18-billion-a-year biologic drug Humira – the world's best-selling prescription medicine – hit the market. (Source: Reuters: Health)
Source: Reuters: Health - August 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Sarilumab Monotherapy vs Adalimumab Monotherapy in RA Sarilumab Monotherapy vs Adalimumab Monotherapy in RA
What benefits might sarilumab monotherapy offer over adalimumab monotherapy in the treatment of rheumatoid arthritis?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 16, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Longer-Term Safety and Efficacy of Adalimumab in Axial Spondyloarthritis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - August 15, 2018 Category: Orthopaedics Tags: Snapshot Source Type: news